84.47

0.82% 0.69

Amedisys Inc (AMED)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$83.78

Offen:

$84.02

24-Stunden-Volumen:

2.19M

Relative Volume:

4.18

Marktkapitalisierung:

$2.77B

Einnahmen:

$2.32B

Nettoeinkommen (Verlust:

$82.93M

KGV:

1,206.71

EPS:

0.07

Netto-Cashflow:

$203.54M

1W Leistung:

-1.41%

1M Leistung:

-6.14%

6M Leistung:

-7.78%

1J Leistung:

-11.11%

1-Tages-Spanne:

$82.15

$84.87

1-Wochen-Bereich:

$82.15

$86.20

52-Wochen-Spanne:

$82.15

$98.95

Amedisys Inc Stock (AMED) Company Profile

Firmenname

Amedisys Inc

Sektor

Healthcare (1176)

Branche

Medical Care Facilities (51)

Telefon

(225) 292-2031

Adresse

3854 AMERICAN WAY, BATON ROUGE, LA

Mitarbeiter

19,000

Twitter

@AmedisysInc

Nächster Verdiensttermin

2024-11-18

Neueste SEC-Einreichungen

AMED's Discussions on Twitter

Vergleichen Sie AMED mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
AMED Amedisys Inc	84.47	2.77B	2.32B	82.93M	203.54M	2.52
HCA Hca Healthcare Inc	303.62	76.91B	69.62B	5.93B	5.88B	22.27
FMS Fresenius Medical Care Ag Adr	22.81	13.39B	20.87B	715.14M	1.67B	1.2209
DVA Davita Inc	151.85	12.46B	12.67B	827.68M	1.42B	9.27
THC Tenet Healthcare Corp	129.46	12.31B	20.97B	3.13B	2.39B	31.21
UHS Universal Health Services Inc	180.11	11.88B	15.42B	1.03B	956.84M	15.02

Amedisys Inc Stock (AMED) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-07-29	Herabstufung	Deutsche Bank	Buy → Hold
2024-07-01	Herabstufung	William Blair	Outperform → Mkt Perform
2023-06-07	Herabstufung	Truist	Buy → Hold
2023-04-21	Eingeleitet	Cantor Fitzgerald	Neutral
2023-03-13	Eingeleitet	Barclays	Equal Weight
2022-10-27	Herabstufung	Raymond James	Outperform → Mkt Perform
2022-08-02	Herabstufung	UBS	Neutral → Sell
2022-06-29	Eingeleitet	Stifel	Hold
2022-06-21	Herabstufung	BofA Securities	Neutral → Underperform
2022-03-01	Hochstufung	UBS	Sell → Neutral
2022-02-25	Hochstufung	BMO Capital Markets	Market Perform → Outperform
2022-02-25	Bestätigt	Credit Suisse	Outperform
2022-02-25	Bestätigt	Oppenheimer	Outperform
2022-02-25	Bestätigt	RBC Capital Mkts	Outperform
2022-02-25	Bestätigt	Raymond James	Outperform
2022-02-25	Bestätigt	Truist	Buy
2021-09-27	Eingeleitet	SVB Leerink	Mkt Perform
2021-09-24	Eingeleitet	UBS	Sell
2021-09-10	Eingeleitet	Cowen	Market Perform
2021-08-10	Bestätigt	The Benchmark Company	Buy
2021-08-05	Herabstufung	BofA Securities	Buy → Neutral
2020-08-20	Fortgesetzt	Barclays	Overweight
2020-07-30	Bestätigt	The Benchmark Company	Buy
2020-06-18	Hochstufung	The Benchmark Company	Hold → Buy
2020-05-07	Herabstufung	The Benchmark Company	Buy → Hold
2020-03-09	Hochstufung	The Benchmark Company	Hold → Buy
2020-01-17	Eingeleitet	Credit Suisse	Outperform
2019-11-01	Hochstufung	Robert W. Baird	Neutral → Outperform
2019-10-22	Fortgesetzt	Stephens	Equal-Weight
2019-09-17	Eingeleitet	Deutsche Bank	Buy
2019-05-02	Hochstufung	Raymond James	Mkt Perform → Outperform
2018-12-14	Eingeleitet	Barclays	Equal Weight
2018-11-16	Eingeleitet	UBS	Neutral
2018-10-30	Hochstufung	The Benchmark Company	Hold → Buy
2018-07-03	Hochstufung	BofA/Merrill	Neutral → Buy
2018-03-19	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2017-11-09	Bestätigt	RBC Capital Mkts	Sector Perform
2017-11-09	Herabstufung	The Benchmark Company	Buy → Hold
2017-11-08	Bestätigt	Mizuho	Buy
2017-11-02	Hochstufung	The Benchmark Company	Hold → Buy
2017-08-21	Eingeleitet	BofA/Merrill	Neutral

Alle ansehen

Amedisys Inc Aktie (AMED) Neueste Nachrichten

Dec 20, 2024

Amedisys stock touches 52-week low at $84.05 amid market shifts - Investing.com Canada

Dec 20, 2024

Dec 19, 2024

Amedisys (NASDAQ:AMED) Hits New 12-Month LowTime to Sell? - MarketBeat

Dec 19, 2024

Amedisys stock touches 52-week low at $84.05 amid market shifts By Investing.com - Investing.com South Africa

Dec 19, 2024

Dec 18, 2024

Justice Department sues to block UnitedHealth Group's $3.3 billion purchase of Amedisys - MSN

Dec 18, 2024

Dec 17, 2024

Amedisys Goes Red - AOL

Dec 17, 2024

State Street Corp Reduces Stock Holdings in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat

Dec 17, 2024

Dec 13, 2024

Justice Department sues to block UnitedHealth’s $3.3 billion Amedisys purchase - MSN

Dec 13, 2024

75,000 Shares in Amedisys, Inc. (NASDAQ:AMED) Bought by Oddo BHF Asset Management Sas - MarketBeat

Dec 13, 2024

National Bank of Canada FI Raises Holdings in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat

Dec 13, 2024

Dec 09, 2024

Quantinno Capital Management LP Grows Stock Position in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat

Dec 09, 2024

Dec 06, 2024

Amedisys (AMED) Down 12.4% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Dec 06, 2024

Dec 05, 2024

UnitedHealthcare CEO Fatally Shot a Month After US DOJ Sues Parent Company's £2.59B Takeover of Amedisys - MSN

Dec 05, 2024

Amedisys, Inc. (NASDAQ:AMED) Shares Sold by Sand Grove Capital Management LLP - MarketBeat

Dec 05, 2024

26,619 Shares in Amedisys, Inc. (NASDAQ:AMED) Acquired by Quarry LP - MarketBeat

Dec 05, 2024

Dec 04, 2024

Melqart Asset Management UK Ltd Has $26.63 Million Position in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat

Dec 04, 2024

Murchinson Ltd. Has $10.17 Million Stake in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat

Dec 04, 2024

Holocene Advisors LP Acquires 62,953 Shares of Amedisys, Inc. (NASDAQ:AMED) - MarketBeat

Dec 04, 2024

Amedisys stock touches 52-week low at $88.72 amid market shifts By Investing.com - Investing.com South Africa

Dec 04, 2024

Charles Schwab Investment Management Inc. Boosts Stake in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat

Dec 04, 2024

Amedisys stock touches 52-week low at $88.72 amid market shifts - Investing.com Nigeria

Dec 04, 2024

Dec 03, 2024

How Amedisys (AMED) Stock Stands Out in a Strong Industry - MSN

Dec 03, 2024

Amedisys is Now Oversold (AMED) - Nasdaq

Dec 03, 2024

Amedisys falls as divestiture buyer in UnitedHealth sale gets legal judgement (update) - Seeking Alpha

Dec 03, 2024